$60.80
▲ +0.1% Today
as of Sep 4, 16:46 ET
Last 30 days
Recent Press Releases & News
Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?
BrightSpring Health Services (BTSG) Could Be 14% Undervalued After Earnings Optimism
2 Reasons to Watch BTSG and 1 to Stay Cautious
Overview
52-week range
$24
$74
74% of range
Avg surprise (last 2)
+76.6%
Avg reaction (last 1)
+16.6%
100% positive
Latest IV / EM
43%
EM ±6.7% · $60 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $0.38 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $0.67 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.26 | — | — | — | — | financials |
| Fri Aug 1, 2025 | Jun/2025 | $0.22 | $0.19 | +15.8% | — | — | earnings |
| Fri May 2, 2025 | Mar/2025 | $0.19 | $0.08 | +137.5% | — | +16.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.04 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.10 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.26 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.11 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.03 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.18 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.87B | $3.61B | — | $3.33B | $3.15B | $2.88B | — | $2.60B |
| Cost of revenue | — | — | — | — | — | — | — | $2.50B |
| Gross profit | $493M | $482M | — | $392M | $375M | $338M | — | $323M |
| Operating income | $130M | $121M | — | $88M | $49M | $51M | — | $29M |
| Net income | $84M | $149M | — | $56M | $28M | $30M | — | $-8M |
| EPS (diluted) | $0.38 | $0.67 | — | $0.26 | $0.13 | $0.14 | — | $-0.04 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $550M | $889M | $88M | $140M | $70M | $52M | $61M | $36M |
| Inventory | $575M | $560M | $815M | $639M | $625M | $534M | $637M | $478M |
| Total current assets | $2.47B | $2.69B | $2.89B | $2.78B | $2.65B | $2.53B | $1.89B | $1.71B |
| Total assets | $5.99B | $6.21B | $6.41B | $6.05B | $5.94B | $5.85B | $5.93B | $5.79B |
| Long-term debt | $2.15B | $2.44B | $2.46B | $2.47B | $2.48B | $2.49B | $2.56B | $2.61B |
| Total liabilities | $3.93B | $4.22B | $4.53B | $4.23B | $4.20B | $4.16B | $4.27B | $4.17B |
| Total equity | $2.05B | $1.98B | $1.88B | $1.82B | $1.74B | $1.69B | $1.65B | $1.61B |